Syra Health (Syra Health) Risk Assessment

View and export this data going back to 2023. Start your Free Trial

What is Syra Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Syra Health is: No Data: Cannot be evaluated.

Competitive Comparison of Syra Health's Risk Assessment

For the Medical Care Facilities subindustry, Syra Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syra Health's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Syra Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Syra Health's Risk Assessment falls into.

Syra Health (NAS:SYRA) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Syra Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of Syra Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Syra Health (Syra Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Syra Health Corp (NAS:SYRA) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

1119 Keystone Way North, No. 201, Carmel, IN, USA, 46032

Website

https://www.syrahealth.com

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health. The Company has two main forms of revenue - healthcare staffing revenue and medical communication revenue. The majority of revenue is derived from healthcare staffing.

Executives

Sandeep Allam	director, officer: President and Chair	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Feroz Syed	10 percent owner	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Deepika Vuppalanchi	director, officer: Chief Executive Officer	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Vijayapal Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Avutu Reddy	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Ketan Paranjape	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Andrew Dahlem	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Sherron Rogers	director	1119 KEYSTONE WAY N., #201, CARMEL IN 46032
Joe D Thomas	10 percent owner	2046 EAST MURRAY-HOLIDAY ROAD, SALT LAKE CITY UT 84117
Sls Group Llc	10 percent owner	6582 S BIG COTTONWOOD CANYON RD. #200, SALT LAKE CITY UT 84121
Priya Prasad	officer: CFO and COO	1119 KEYSTONE WAY N., #201, CARMEL IN 46032